Last reviewed · How we verify
Staphylococcus Nosocomial Pneumonia
Approved treatments
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcus Nosocomial Pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcus Nosocomial Pneumonia treatment landscape brief
- Staphylococcus Nosocomial Pneumonia treatment updates RSS
Frequently asked questions about Staphylococcus Nosocomial Pneumonia
What drugs treat Staphylococcus Nosocomial Pneumonia?
Tracked treatments include Pipracil, Zosyn.
What is the treatment for Staphylococcus Nosocomial Pneumonia?
Standard treatment for Staphylococcus Nosocomial Pneumonia includes Pipracil, Zosyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcus Nosocomial Pneumonia patent cliff · Staphylococcus Nosocomial Pneumonia CI report
- Treatment: Pipracil
- Treatment: Zosyn · Merck Sharp & Dohme B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing